Skip to content

Ayurvedic Management in Deafness

Role Of BilwadiI Taila Karnapurana And Shadbindu Taila Nasya Along With Sarivadi Vati In The Managment Of Badhirya [Sensory Neural Hearing Loss ]

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011642
Enrollment
30
Registered
2018-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- degree of hearing loss greater than 25db less than 80db

Interventions

Intervention1: GROUP-A: Karnapurana with Bilwadi Taila 2ml along with Sarivadi Vati 250 mg1 tablet thrice a day for 1 month Control Intervention1: GROUP-B: Nasya with Shadbindu Taila 6 drops each n

Sponsors

institute for Post Graduate Teaching And Research In Ayurveda Jamnagar Gujarat Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients in the age group 18 to 60 years irrespective of age sex caste religion 2 Degree of hearing loss greater than 25 less than 80 dB SNHL

Exclusion criteria

Exclusion criteria: 1 Age below 18 year and above 60 year 2 Degree of hearing loss greater than 80 dB 3 Conductive deafness 4 Mixed hearing loss 5 Middle ear pathology 6 Inner ear pathology like acoustic neuroma Menieres disease Etc 7 Genetic SNHL 8 Syphilic SNHL 9 Psychogenic hearing loss 10 Systemic diseases: e.g. Diabetes, Hypothyroidism, Renal disorders, Autoimmune disorders, Multiple sclerosis etc. • Malignancy etc. •Patient who need surgical intervention

Design outcomes

Primary

MeasureTime frame
Significance Level Of DeafnessTimepoint: 4 Weeks

Secondary

MeasureTime frame
Significant relief in the sign and symptoms of deafnessTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr D B Vaghela

Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026